Pharmamarketeer

Pfizer/BioNTech file for FDA approval for COVID-19 booster jab

COVID-19 booster

Pfizer and BioNTech have filed a supplemental Biologics License Application (sBLA) with the US Food and Drug Administration (FDA) for the approval of a third dose of their Cominarty COVID-19 vaccine for those aged 16 years and older.

Advertentie(s)